Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
By C. Gieger, L. Geistlinger, E. Altmaier, M. Hrabě de Angelis, F. Kronenberg, T. Meitinger, Hans-Werner Mewes, H. Wichmann, K. Weinberger, Jerzy Adamski and 2 more. PLoS Genetics, 2008
760 citations recorded by the source corpus.
The rapidly evolving field of metabolomics aims at a comprehensive measurement of ideally all endogenous metabolites in a cell or body fluid. It thereby provides a functional readout of the physiological state of the human body. Genetic variants that associate with changes in the homeostasis of key lipids, carbohydrates, or amino acids are not only expected to display much larger effect sizes due to their direct involvement in metabolite conversion modification, but should also provide access to the biochemical context of such variations, in particular when enzyme coding genes are concerned. To test this hypothesis, we conducted what is, to the best of our knowledge, the first GWA study with metabolomics based on the quantitative measurement of 363 metabolites in serum of 284 male participants of the KORA study. We found associations of frequent single nucleotide polymorphisms (SNPs) with considerable differences in the metabolic homeostasis of the human body, explaining up to 12% of the observed variance. Using ratios of certain metabolite concentrations as a proxy for enzymatic activity, up to 28% of the variance can be explained (p-values 10−16 to 10−21). We identified four genetic variants in genes coding for enzymes (FADS1, LIPC, SCAD, MCAD) where the corresponding metabolic phenotype (metabotype) clearly matches the biochemical pathways in which these enzymes are active. Our results suggest that common genetic polymorphisms induce major differentiations in the metabolic make-up of the human population. This may lead to a novel approach to personalized health care based on a combination of genotyping and metabolic characterization. These genetically determined metabotypes may subscribe the risk for a certain medical phenotype, the response to a given drug treatment, or the reaction to a nutritional intervention or environmental challenge.
Subfields: Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/85ff64f1c305583d564343fa54bacb69f28b232a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- Robert E. W. Hancock
- Serena Sanna
- Jianguo Xia
- Dale R. Nyholt
- David S. Wishart
- Aldons J. Lusis
- Yan V. Sun
- Mete Civelek
In Molecular Biology
- Jianguo Xia
- David S. Wishart
- Igor Sinelnikov
- Beomsoo Han
- Erin E. Gill
- Robert E. W. Hancock
- Serena Sanna
- A. Valdes
Citations in the corpus
- Systems genetics approaches to understand complex traits (2013, background): “A recent study using a large cross between two yeast strains provided an estimate of the importance of epistatic interactions for 46 highly heritable complex traits 57 .”
- A genomewide perspective of genetic variation in human metabolism (2009, background): “We have previously identified frequent genetic polymorphisms with large effects that alter an individual's metabolic capacitie”
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent (2016, positive): “In cases where a pair of PI species is likely related to the substrate and product of a given enzymatic reaction, such ratios can serve as a surrogate for enzymatic activity 45 .”
- NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data (2015, background): “…into functional associations KEGG—Kyoto Encyclopedia of Genes and Genomes: http://www.genome.jp/kegg/ Limma—Linear models for microarray data LPS—Lipopolysaccharide: bacterial signature molecule that interacts with Toll-like receptor 4 on host cells to trigger innate immune/ inflammatory responses.”
- Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016, background): “Several systems genetics studies of metabolites in human plasma or serum have been reported (Gieger et al., 2008; Kettunen et al., 2012; Shin et al., 2014; Suhre et al., 2011; Yu et al., 2013).”
- Targeted Metabolomics (2012, background): “Gieger et al. (2008) integrated genome-wide analyses of common human variants with serum measurements of 363 metabolites in 284 male participants of the Cooperative Research in the Region of Augsburg (KORA) study.”
- Gene-Environment-Wide Association Studies: Emerging Approaches (2010, neutral): “A promising approach entails incorporating metabolomics, as in the first GWA study of a large panel of metabolite phenotype”
- An atlas of genetic influences on human blood metabolites (2014, background): “58 Pantothenate and CoA (1) 56 Hemoglobin and porphyrin (5) 55 Tocopherol (2) 53 Fibrinogen cleavage peptide (3) 52 Dipeptide (9) 49 Polyamine metabolism (1) 48 Amino fatty acid (1) 47 Guanidino and acetamido (1) 45 Tryptophan (10) 44 Glutathione (2) 42 Branched-chain amino acid (14) 41 Butanoate (3”
- MetaboAnalyst 3.0—making metabolomics more meaningful (2015, background): “Additionally there are now growing numbers of complex, multi-omic studies being performed that integrate metabolomics data with genomics, epigenomics or proteomics data over large populations (11–15).”